Skip to Main Content

Paper Details

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod.
0
2023
548a, 548a-3p, MS, Multiple sclerosis, NEDA-, RRMS, autoimmune demyelinating disorder, fingolimod, glatiramer acetate, human, interferon, miR, miR-548a-3p, miRNA, miRNA 548a-3p, microRNA, multiple sclerosis, patients, people, serum miRNAs
Author NameAffiliation
Howard L WeinerHarvard Medical School
Howard L WeinerBrigham and Women's Hospital
  • 1 - 2

Datasets

Release 1.2